# Arintra

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arintra

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.arintra.com
- Total disclosed funding: $46M
- Latest round: Series B (Aug 20, 2026)
- Investors on record: 10

## About

Based in San Francisco, US, founded in 2020, Arintra, Inc specializes in autonomous medical coding solutions that integrate within electronic health record systems. The company was co-founded by Preeti Bhargava and Nitesh Shroff (CEO as of 2026). In August 2026, Arintra, Inc raised USD 25 million in series B funding led by Define Ventures, with participation from Yale New Haven Hospital, Endeavor Ventures, Y Combinator, TEN13, Counterpart Ventures, Spider Capital, and Peak XV Partners. 

Arintra specializes in GenAI-powered autonomous medical coding solutions integrated within electronic health record (EHR) systems, designed to enhance revenue cycle management for healthcare organizations. Their offerings streamline the coding process by ensuring accurate, guideline-based coding and documentation, which reduces administrative workloads and enhances compliance for healthcare providers. The solutions are targeted at healthcare systems across the United States, serving a diverse clientele, including hospitals and smaller healthcare organizations. They have gained recognition for delivering substantial improvements in coding accuracy and minimizing billing delays and denials.

Arintra's revenue model is primarily based on subscription agreements, providing healthcare organizations access to its advanced coding platform and ongoing support services. Clients enter into service agreements that ensure continuous access to Arintra’s tools, including its flagship autonomous medical coding solution that integrates with existing EHR systems like Epic. Clients pay based on various tiers of usage or features, which may include updates aligned with regulatory changes. This subscription-based model promotes stable revenue streams while enabling healthcare providers to realize significant cost savings and enhance their revenue cycle operations.

The company plans to use the August 2026 funding to help scale its autonomous billing technology across health systems and specialty groups.

## Funding rounds

- Series B, Aug 20, 2026, $25M — Y Combinator, Yale New Haven Hospital, Spider Capital, Counterpart Ventures, Define Ventures, Endeavour Ventures, TEN13, Peak XV Partners
- Series A, Aug 12, 2025, $21M — Y Combinator, Endeavor Health, Spider Capital, FoundersX Ventures, Counterpart Ventures, TEN13, Peak XV Partners
- Seed, Jun 30, 2023 — Peak XV Partners

## Investors

- Peak XV Partners (https://capitalatlas.ai/funds/peak-xv-partners) — Seed, Series A, Series B
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Series A, Series B
- Endeavor Health — Series A
- Spider Capital (https://capitalatlas.ai/funds/spider-capital) — Series A, Series B
- FoundersX Ventures (https://capitalatlas.ai/funds/foundersx-ventures) — Series A
- Counterpart Ventures (https://capitalatlas.ai/funds/counterpart-ventures) — Series A, Series B
- TEN13 (https://capitalatlas.ai/funds/ten13) — Series A, Series B
- Yale New Haven Hospital — Series B
- Define Ventures (https://capitalatlas.ai/funds/define-ventures) — Series B
- Endeavour Ventures (https://capitalatlas.ai/funds/endeavour-ventures) — Series B